Sam – Page 299 – biolegacy

The trade association of the British drug industry dropped its legal challenge to new guidelines from national regulators that subject higher-priced drugs to an extra review under England’s single-payer National…

Fiscal 2017 Ends With Record High in ANDA Approvals

Post author:Sam
Post published:October 5, 2017
Post category:Drug Industry Daily

For fiscal 2017, the FDA approved 763 generic drug applications, beating the previous year’s record of 651 by 17 percent. An additional 174 were granted tentative approval. Source: Drug Industry…

Gottlieb Urges Transition to Abuse-Deterrent Opioid Formulations

Post author:Sam
Post published:October 5, 2017
Post category:Drug Industry Daily

The FDA strongly supports transitioning the opioid painkiller market toward abuse-deterrent formulations, Commissioner Scott Gottlieb told a Senate committee examining the abuse epidemic. Source: Drug Industry Daily

Cambridge-Based Biotech Scoops Up $46.7 Million in Funding Round

Post author:Sam
Post published:October 4, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Cambridge-Based Biotech Scoops Up $46.7 Million In Funding Round" ALT"Cambridge-Based Biotech Scoops Up $46.7 Million In Funding Round"October 5, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR... Source: BioSpace

Cepheid Wins FDA Nod to Market Xpert Xpress Strep A

Post author:Sam
Post published:October 4, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

<b>PharmaSeek</b> Offers Solution to Slow Payments In The Clinical Research Industry

Post author:Sam
Post published:October 4, 2017
Post category:BioPharma

MADISON, WI--(Marketwired - September 29, 2017) - PharmaSeek, an Investigative Site Network, has launched a new service aimed at eliminating the burden of slow payments for clinical research sites. This…